Brazil – Class II Medical Devices – New Resolution
A new Resolution of the Collegiate Board of Directors (RDC No. 423/2020) has been published by Brazil’s National Agency of Health Surveillance (ANVISA). This new Resolution announces the elimination of the ‘Cadastro’ pathway regarding the registration of medical devices (Class II) and IVDs, substituting it with a notification registration system.

Date

Liliana Teles

Liliana Teles

Regulatory Affairs Manager

MEDICAL DEVICES LEGAL FRAMEWORK IN BRAZIL

Medical devices placed in the Brazilian market must be registered at Brazil’s National Agency of Health Surveillance (ANVISA), in accordance with the Brazilian Resolution RDC. No. 185. Manufacturers or importers of such products need to submit to ANVISA all the documents required for their registration as well as for their alteration, revalidation or cancellation. After evaluating all the documentation for registration, alteration, revalidation or cancellation, ANVISA publishes its decision on the Brazilian Official Gazette (DOU).

According to the risk they represent to consumers, patients, operators or third parties involved, medical products are classified as Class I, II, III or IV. In case of doubts in the classification, ANVISA is the one classifying the medical device.

Until recently, Class II medical devices were subject to a short registration process called ‘Cadastro’ (pre-market approval). Manufacturers of Class II medical devices (and some Class I) were requested to provide technical dossiers, labelling materials and proposed indications of use (IFU) documents to their Brazilian Registration Holder (BRH) representative in the country.

NEW RESOLUTION ON MEDICAL DEVICES CLASS II

According to the new Resolution published in September 2020, as it happens with Class I medical devices, Class II devices only require a formal notification (‘Notificação’) and no longer need an approval by ANVISA before entering the market. This notification shall be done using a special form available at ANVISA’s website. Now, manufacturers do not need to submit a technical dossier but should have these documentation available upon request (in case of an inspection by ANVISA). The main goal of the new Resolution is to help ANVISA to focus on high-risk medical products.

IVDs (Class I and II) may now also enter the Brazilian market via the notification pathway.

Class II medical devices that are already registered in ANVISA do not require a re-validation (except if changes are requested).

References:

  1. Resolução da Diretoria Colegiada – RDC Nº 423, de 16 se Setembro 2020. Available at: https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/09/2020&jornal=515&pagina=110&totalArquivos=139
  2. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolution RDC No. 185, of October 22nd, 2001. Available at: https://www.emergobyul.com/sites/default/files/file/rdc_185_2001_classification_and_registration_requirements_of_medical_products_0.pdf
  3. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolução da Diretoria Colegiada – RDC Nº 270, de 28 de Fevereiro de 2019. Available at: http://rapassarini.com.br/wp-content/uploads/2019/03/RESOLUC%CC%A7A%CC%83O-DA-DIRETORIA-COLEGIADA-RDC-N%C2%BA-270-DE-28-DE-FEVEREIRO-DE-2019-Dia%CC%81rio-Oficial-da-Unia%CC%83o-Imprensa-Nacional.pdf
  4. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolução da Diretoria Colegiada – RDC Nº 27, de 21 de Junho de 2011. Available at: http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2011/rdc0027_21_06_2011.pdf

further
reading

cosmetic products

BREXIT e os Produtos Cosméticos Comercializados em Portugal

No passado dia 22 deste mês, o INFARMED, I.P., emitiu uma Circular Informativa, onde concede um período transitório de 6 meses às empresas, cuja Pessoa Responsável está sediada no Reino Unido e que desejam continuar a ter os seus produtos cosméticos disponíveis no mercado nacional, para que possam enviar toda a documentação e informação necessárias.

Read More »
cosmetic products

Virginia – The Fourth State to Ban Animal Testing in the U.S.

In the United States (U.S.), Virginia is the fourth state to ban animal testing in cosmetic products. The Governor of this state (Ralph Northam) has signed this month (March 2021) a bill and the ban will start on January 1st, 2022. The sale of cosmetics tested on animals will also be prohibited from July 1st, 2022.

Read More »
cosmetic products

France Anti-Waste Law

On February 11th, 2020, the Loi relative à la lute contre le gaspillage et a l’économie circulaire (Anti-Waste for a circular economy) has come officially into force in France. The law provides for a ban on all single-use plastics by 2040.

Read More »
cosmetic products

EU Reduction of the Impact of Certain Plastic Products on the Environment

Cosmetics and personal care industry are a growing business, but with this growth comes a major concern: plastic pollution.
The European Commission has published the Directive (EU) 2019/904, known as Single-Use Plastic Directive. This directive addresses the reduction of the impact of certain plastic products on the environment. Harmonized marking specifications are laid down on the Commission Implementing Regulation (EU) 2020/2151.

Read More »
medical devices

BREXIT – Impact on Medical Devices placed in the UK market

From 31 of December 2020, the UK will be regarded as a third country and not a Member State of the European Union. There will be some changes regarding medical devices placed in the UK. The UK’s MHRA has published guidance regarding the regulation of medical devices from 1 January 2021, where it explains what changes and what there is to know about placing a medical device in the Great Britain, Northern Ireland and EU markets.

Read More »
medical devices

Brazil – Class II Medical Devices – New Resolution

A new Resolution of the Collegiate Board of Directors (RDC No. 423/2020) has been published by Brazil’s National Agency of Health Surveillance (ANVISA). This new Resolution announces the elimination of the ‘Cadastro’ pathway regarding the registration of medical devices (Class II) and IVDs, substituting it with a notification registration system.

Read More »
cosmetic products

Butylphenyl Methylpropional to be prohibited in cosmetics placed in the EU market

Butylphenyl Methylpropional, also known as Lilial, is a fragrance ingredient that has been used for years in several cosmetic and non-cosmetic products. Nevertheless, some concerns have been expressed regarding the use of this ingredient and its risk to consumers. According to an amendment to the CLP Regulation (Commission Delegated Regulation No. 2020/1182), Butylphenyl Methylpropional is now classified as toxic to reproduction (Repr. 1B – CMR 1B) and it shall be prohibited in cosmetic products from 1st March 2022.

Read More »
cosmetic products

China Bans Microbeads in Cosmetics

On 16th January 2020, China’s National Development and Reform Commission (NDRC) issued the Notice [2020] No. 80, with the aim of prohibiting the use of microbeads in cosmetics and personal care products. More detailed information was given in the Notice [2020] No. 1146, issued by the NDRC on 10th July 2020.

Read More »
medical devices

EU Medical Devices Regulation – Unique Device Identifier (UDI)

In 2017, two Regulations on medical devices (MDR) and in in vitro diagnostic medical devices (IVDR) entered into force in the European Union (EU), establishing a modernized and more robust EU legislative framework and safeguarding a better public health protection and patient safety. According to the these Regulations, the Unique Device Identifier (UDI) will be mandatory for all medical devices and in vitro medical devices.

Read More »
COVID-19

FDA updates on hand sanitizers safety for use

The U.S. Food and Drug Administration (FDA) has announced that it is providing a new laboratory testing method to assess the quality of finished hand sanitizers. Moreover, the FDA has issued a new press release on August 27th 2020, where it warns consumers about hand sanitizers packaged in food and drink containers. Earlier this month, the FDA expanded hand sanitizer warnings to include 1-propanol contamination.

Read More »
cosmetic products

RAPEX System 2019 Report

Every week, the RAPEX system publishes notifications of urgent measures taken by EU Member-States to prevent, restrict or impose conditions on the marketing of products due to the serious and immediate danger they pose to the health and safety of consumers.

Read More »
cosmetic products

Cosmetic Packaging in European Union

Packaging material is defined as the container (or primary packaging) that is in direct contact with the formulation. According to the European Cosmetic Regulation No. 1223/2009, packaging evaluation is mandatory to guarantee cosmetic product safety. To meet this Regulation requirements, the European Commission issued the Decision 2013/674/EU, establishing guidelines on the practical application of such requirements and identifying information that should be collected on the packaging materials and the potential migration of substances from packaging.

Read More »